TARO Taro Pharmaceutical Industries Ltd

Taro Pharmaceutical Industries Ltd is a science-based pharmaceutical company. It develops, manufacture and market Rx and OTC (over-the-counter) pharmaceutical products primarily in the United States, Canada and Israel.

$73.07  -1.76 (-2.35%)
As of 06/18/2021 16:00:02 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  Israel
Country of incorporation:  Israel
IPO date:  02/11/2013
Outstanding shares:  38,258,077
Average volume:  27,576
Market cap:   $2,862,851,902
Current dividend yield:  13.23%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    M8737E108
ISIN:        IL0010827181
Sedol:      2872423
Valuation   (See tab for details)
PE ratio:   -7.23
PB ratio:   1.63
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy